Posted by & filed under Company Analysis, Financial analysis, Growth & Valuation, Management Issues.

Description: Valeant Pharmaceuticals said on Monday that it was willing to raise its offer for the Botox maker Allergan, and once again invited the company to negotiate a friendly deal.


Date: Oct 27, 2014


Questions for Discussions:

  • What will the affect of a $200 offer be on both firms’ stock values?
  • Do you think the strategy of publically offering this price is a correct one?

Leave a Reply

Your email address will not be published. Required fields are marked *